A California cooperative clinical study comparing allogeneic hematopoietic cell transplantation using nonmyeloablative host conditioning with total lymphoid irradiation and anti-thymocyte globulin versus best standard of care in acute myeloid leukemia (AML) in first complete remission

Trial Profile

A California cooperative clinical study comparing allogeneic hematopoietic cell transplantation using nonmyeloablative host conditioning with total lymphoid irradiation and anti-thymocyte globulin versus best standard of care in acute myeloid leukemia (AML) in first complete remission

Discontinued
Phase of Trial: Phase III

Latest Information Update: 22 Nov 2013

At a glance

  • Drugs Antineoplastics; Antithymocyte globulin; Ciclosporin; Mycophenolate mofetil
  • Indications Acute myeloid leukaemia; Bone marrow transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 05 Jun 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
    • 04 Sep 2009 Planned end date (Dec 2011) added as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top